Tumor Mutational Burden in Lung Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intratumoral Microdosing of Motolimod in HNSCC
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time
- Status
- COMPLETED
- Phase
- PHASE1
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
COL Immunotherapy Before Radiochimio + Ipilimumab
- Status
- COMPLETED
- Phase
- NA
A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
- Status
- COMPLETED
- Phase
- N/A
A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3